F122 Discoveries that Will Change Your Practice: Basic Science Updates for Dermatologists
DESCRIPTION
The session will be focused on reviewing recent basic science discoveries within lupus, dermatomyositis, cutaneous T-Cell lymphoma, melanoma, the microbiome and neuropathic itch and their impact on the practice of dermatology. The session will be directed toward practicing dermatologists looking to stay up to date with scientific literature and dermatology residents looking for additional board preparation and practice preparation.
Scientific literature is expanding at a rate that makes reviewing all pertinent literature in one's field impossible. Practicing dermatologists often find it difficult to keep up with basic science advances, in favor of reading clinical journals. However, basic science advances inform therapeutic options, and prognostication of side effects, response to therapy and patient survival. Our goal is to translate recent scientific advances into actionable clinical practice updates.
LEARNING OBJECTIVES
Summarize updates in microbiome research and the effects on the practice of dermatology
Summarize updates in the pathogenesis of lupus, dermatomyositis, cutaneous T cell lymphoma, melanoma, and neuropathic itch and the effects on the practice of dermatology
SCHEDULE
3:30 PM
Advances in neuropathic itch
Jesse J Keller, MD, FAAD
3:50 PM
Microbiome in dermatology
Teri Seeberger Greiling, MD, PhD, FAAD
4:10 PM
Advances in Mucosal Dermatology
Erin Foster, MD, FAAD
4:30 PM
Molecular diagnosis/mutation analysis as prognostic factors in melanoma
Elizabeth Gates Berry, MD, FAAD
4:50 PM
Cutaneous T-cell lymphoma
Jina Chung, MD, FAAD
5:10 PM
Panel discussion/Q&A
DIRECTOR
Jesse J Keller, MD, FAAD
SPEAKERS
Elizabeth Gates Berry, MD, FAAD
Jina Chung, MD, FAAD
Erin Foster, MD, FAAD
Teri Seeberger Greiling, MD, PhD, FAAD
DISCLOSURES
Elizabeth Gates Berry, MD, FAAD
Barco N.V. – Consultant(Fees); Bristol-Myers Squibb – Advisory Board(Fees); Orlucent – Investigator(Grants/Research Funding);
Jina Chung, MD, FAAD
No financial relationships exist with ineligible companies.
Erin Foster, MD, FAAD
Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); National Eczema Association – Consultant (1099 relationship)(No Compensation Received);
Teri Seeberger Greiling, MD, PhD, FAAD
Biogen – Independent Contractor(Salary); Concerto Biosciences – Consultant (1099 relationship)(Honoraria); Janssen Scientific Affairs, LLC – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Honoraria); Schro¨dinger, Inc – Consultant (1099 relationship)(Honoraria); UpToDate – Consultant(Honoraria); VisualDx – Consultant (1099 relationship)(Honoraria);
Jesse J Keller, MD, FAAD
No financial relationships exist with ineligible companies.